Speaker(s): 

Ryley B. Uber, PharmD, Pharmacogenomics Program Director, Enterprise Pharmacy; Assistant Professor, Center for Pharmacy Innovations and Outcomes (CPIO) and Department of Pharmacy, Geisinger College of Health Sciences. - has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. ​​​​​​​Explain how pharmacogenomic data is integrated into clinical workflows at Geisinger and how this is expected to enhance medication safety and treatment outcomes.
2. Identify key components of Geisinger’s Pharmacogenomics Program, including the clinical consult service, informatics infrastructure, and research initiatives.
3. Discuss the future directions of Geisinger’s Pharmacogenomics Program and the broader field of pharmacogenomics.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Candice Laubach, MBA, Christa Martin, PhD, Jennifer Nunamaker, Christian Lynch, MPH, Eric Wright, PharmD, MPH, Adam Buchanan, MS, MPH, CGC, and David Rolston, MD, FACP have no identified disclosures. 

The presenter, Dr. Ryley Uber has nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None